1. Home
  2. WEX vs LGND Comparison

WEX vs LGND Comparison

Compare WEX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WEX Inc. common stock

WEX

WEX Inc. common stock

HOLD

Current Price

$197.77

Market Cap

6.1B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$305.27

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEX
LGND
Founded
1983
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.0B
IPO Year
2004
1997

Fundamental Metrics

Financial Performance
Metric
WEX
LGND
Price
$197.77
$305.27
Analyst Decision
Buy
Strong Buy
Analyst Count
15
11
Target Price
$195.36
★ $344.25
AVG Volume (30 Days)
★ 461.0K
196.3K
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
12.93
★ 2886.36
EPS
★ 5.33
1.63
Revenue
★ $2,660,800,000.00
$141,102,000.00
Revenue This Year
$8.92
$8.04
Revenue Next Year
$1.57
$31.71
P/E Ratio
★ $37.18
$188.34
Revenue Growth
1.24
★ 29.48
52 Week Low
$125.29
$175.89
52 Week High
$203.99
$326.63

Technical Indicators

Market Signals
Indicator
WEX
LGND
Relative Strength Index (RSI) 69.70 54.61
Support Level $183.52 $277.97
Resistance Level $203.97 $318.30
Average True Range (ATR) 4.68 11.25
MACD 3.16 0.38
Stochastic Oscillator 96.34 69.08

Price Performance

Historical Comparison
WEX
LGND

About WEX WEX Inc. common stock

WEX Inc is a commerce platform that provides seamlessly embedded, personalized payments solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. Its prime end market is the United States of America.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: